David Loew is the CEO of Ipsen (IPSEY). Loew is based in France. Loew was born in 1967 and educated at University of St. Gallen.
David Loew is a pharmaceutical executive with nearly 30 years of industry experience. He joined Ipsen as CEO in July 2020 after leading Sanofi Pasteur Vaccines, and previously held senior positions at Roche spanning oncology, marketing, and regional leadership across multiple therapeutic areas.
Recent developments
AI summary of recent coverageRecent coverage of David Loew at Ipsen has focused on the company's strategic positioning in rare diseases and specialty care, including exploration of U.S. manufacturing investments and pursuit of acquisition opportunities with substantial capital. Headlines also reflect Loew's leadership approach to navigating industry challenges such as patent cliffs and the perceived risks within gene therapy development.
Summarized from the headlines below; see each source for the full story.
Key Facts
Source: Wikidata ↗- Born
- March 20, 1967
- Citizenship
- Switzerland
- Education
- University of St. Gallen
Our coverage
On CEOInsider
No feature yet. When we publish a feature, interview or cover story on David Loew, it will appear here — and tie into the news timeline.
David Loew: FAQ
- Who is David Loew?
- David Loew is the Chief Executive Officer of Ipsen, based in France.
- What company does David Loew lead?
- David Loew is CEO of Ipsen.
- Where was David Loew educated?
- David Loew studied at University of St. Gallen.